Quantitative and qualitative assessment of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cell immunity to gag in HIV-1-infected individuals with differential disease progression:: Reciprocal interferon-γ and interleukin-10 responses

被引:76
作者
Ostrowski, MA
Gu, JX
Kovacs, C
Freedman, J
Luscher, MA
MacDonald, KS
机构
[1] Univ Toronto, Dept Med, Div Clin Sci, Toronto, ON, Canada
[2] St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada
[3] Mt Sinai Hosp, Dept Microbiol, Toronto, ON M5G 1X5, Canada
[4] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada
关键词
D O I
10.1086/324005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The human immunodeficiency virus type 1 (HIV-1)-specific CD4(+) T cell response was investigated in 33 untreated HIV-1-infected individuals, using highly sensitive ELISPOT assays and intracellular flow cytometry. The median frequencies of interferon (IFN)-gamma -producing HIV-1 gag-specific CD4(+) T cells did not correlate significantly with control of viral replication or progression. HIV-1 gag-specific interleukin (IL)-4-producing cells were rarely detected. Circulating frequencies of CD4(+) T cells constitutively producing IL-10, however, were significantly higher in individuals with progression or active replication. In 17 of 30 HIV-1-infected individuals, gag antigen was observed to induce IL-10 production from CD4(+) T cells. In 2 individuals, early treatment of acute HIV- 1 infection "rescued" low to undetectable gag-specific IFN-gamma -producing CD4(+) T cell responses and dramatically down-regulated constitutive IL-10 production from circulating CD4(+) T cells. The detection of HIV-1-specific IL-10-inducing CD4(+) T cells in HIV-1-infected individuals suggests that HIV- 1 may directly subvert specific immune responses by IL-10 induction.
引用
收藏
页码:1268 / 1278
页数:11
相关论文
共 40 条
  • [1] The use of a rapid ELISPOT assay to analyze peptide-specific immune responses in carcinoma patients to peptide vs. recombinant poxvirus vaccines
    Arlen, P
    Tsang, KY
    Marshall, JL
    Chen, A
    Steinberg, SM
    Poole, D
    Hand, PH
    Schlom, J
    Hamilton, JM
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2000, 49 (10) : 517 - 529
  • [2] Bleijs DA, 1999, EUR J IMMUNOL, V29, P2248, DOI 10.1002/(SICI)1521-4141(199907)29:07<2248::AID-IMMU2248>3.0.CO
  • [3] 2-9
  • [4] IL-10-producing T cells suppress immune responses in anergic tuberculosis patients
    Boussiotis, VA
    Tsai, EY
    Yunis, EJ
    Thim, S
    Delgado, JC
    Dascher, CC
    Berezovskaya, A
    Rousset, D
    Reynes, JM
    Goldfeld, AE
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (09) : 1317 - 1324
  • [5] Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo
    Callan, MFC
    Tan, L
    Annels, N
    Ogg, GS
    Wilson, JDK
    O'Callaghan, CA
    Steven, N
    McMichael, AJ
    Rickinson, AB
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (09) : 1395 - 1402
  • [6] DETECTION OF 3 DISTINCT PATTERNS OF T-HELPER CELL DYSFUNCTION IN ASYMPTOMATIC, HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE PATIENTS - INDEPENDENCE OF CD4+ CELL NUMBERS AND CLINICAL STAGING
    CLERICI, M
    STOCKS, NI
    ZAJAC, RA
    BOSWELL, RN
    LUCEY, DR
    VIA, CS
    SHEARER, GM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (06) : 1892 - 1899
  • [7] CHANGES IN INTERLEUKIN-2 AND INTERLEUKIN-4 PRODUCTION IN ASYMPTOMATIC, HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE INDIVIDUALS
    CLERICI, M
    HAKIM, FT
    VENZON, DJ
    BLATT, S
    HENDRIX, CW
    WYNN, TA
    SHEARER, GM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (03) : 759 - 765
  • [8] Flanagan KL, 1999, EUR J IMMUNOL, V29, P1943, DOI 10.1002/(SICI)1521-4141(199906)29:06&lt
  • [9] 1943::AID-IMMU1943&gt
  • [10] 3.0.CO